Eileen Boyle, MD, PhD, University College London, London, UK, briefly explains the criteria used to define smoldering multiple myeloma (SMM), highlighting the SLiM CRAB criteria developed by the IMWG. Dr Boyle further comments on the importance of better understanding myeloma-defining events and correctly categorizing patients who may require treatment. This interview took place at the 9th World Congress on Controversies in Multiple Myeloma (COMy) 2023, held in Paris, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.